| Structure | Chemical Name | CAS | MF |
|
CALVACIN
|
9012-59-3
|
|
|
|
CALVADOS
|
|
|
|
calvatic acid
|
54723-08-9
|
C8H5N3O3
|
|
|
canals sealer
|
|
|
|
|
canaliculus domain-specific glycoprotein gp110
|
|
|
|
|
Canamycin A disulfate salt dihydrate VETRANAL
|
|
|
|
|
calumenin
|
|
|
|
|
CANANGA ODORATA FLOWER WAX
|
|
|
|
|
CANANGA ODORATA FLOWER EXTRACT
|
|
|
|
|
CANANGAODORATA
|
|
|
|
|
CANANADO
|
|
|
|
|
CANANGA OIL
|
68606-83-7
|
|
|
|
Ylang Ylang Oil
|
8006-81-3
|
|
|
|
CALVER(R) 2 CALCIUM INDICATOR
|
|
|
|
|
CaMK-related protein
|
|
|
|
calurin
|
52080-78-1
|
C10H12N2O5
|
|
|
CANARY
|
|
|
|
|
CANARY-GRASSSEED
|
|
|
|
|
CANARYPALM
|
|
|
|
|
CANARIUMCOMMUNE
|
|
|
|
|
Canarium commune, ext.
|
97675-63-3
|
|
|
canarigenin
|
1778-88-7
|
C23H32O4
|
|
|
Calvital
|
102903-12-8
|
|
|
CALVINPHOS
|
6465-92-5
|
C4H7Cl2O4P.2C3H4Cl2O4P.Ca
|
|
Canbisol
|
56689-43-1
|
C24H38O3
|
|
Calusterone
|
17021-26-0
|
C21H32O2
|
|
|
canatoxin
|
80701-28-6
|
|
|
CANCA
|
22541-14-6
|
H2Pr+3
|
|
Canavanine, tetra(trimethylsilyl)-
|
|
C17H44N4O3Si4
|
|
|
canavalin
|
|
|
|
canavanine phenylhydrazide
|
|
C11H18N6O2
|
|
|
canavanine hydrolase
|
|
|
|
canavanine-bis-(2-chloroethyl)hydrazide
|
|
C9H20Cl2N6O2
|
|
canavalmine
|
70862-15-6
|
C11H28N4
|
|
|
CANAVALIAENSIFORMIS
|
|
|
|
|
CANAVALIAGLADIATA
|
|
|
|
|
Canavalia gibberellin Ⅰ
|
|
C19H22O7
|
|
|
CANAVALIA ENSIFORMIS LEAF EXTRACT
|
|
|
|
|
CANAVALIA GLADIATA SEED EXTRACT
|
|
|
|
|
CANAVALIA GLADIATA FRUIT EXTRACT
|
|
|
|
Canavalia gibberellin I
|
18450-93-6
|
C19H22O7
|
|
|
CA 0.45 250MM DOE FLAT GSKT
|
|
|
|
|
CA 0.20 250MM DOE FLAT GSKT
|
|
|
|
|
CA 0.45 500MM DOE FLAT GSKT
|
|
|
|
|
CA 0.20 500MM DOE FLAT GSKT
|
|
|
|
|
CA 0.45 250MM DOE FLAT GSKT EPR
|
|
|
|
|
CBDcex*TAG ANTIBODY
|
|
|
|
|
Cancer Associated Antigen, Ovarian Tumor, Cell Culture Deriv
|
|
|
|
|
CA 0.45 250MM 2-222EPR/FLAT
|
|
|
|
|
Camlofyn HCL
|
|
|
|
|
CBDcenA*TAG ANTIBODY
|
|
|
|
|
cancerocerebral antigen
|
|
|
|
|
cancer basic protein
|
|
|
|
|
CANCERRISKASSESSMENT
|
|
|
|
|
cancer procoagulant
|
109456-80-6
|
|
|
|
Cancell
|
|
|
|
|
CANCEREPIDEMIOLOGY:GENERAL
|
|
|
|
|
CANCERMECHANISMS
|
|
|
|
|
CANCER
|
|
|
|
|
CANCEREPIDEMIOLOGY:INDUSTRIAL
|
|
|
|
|
CANCEREPIDEMIOLOGY:LIFESTYLE
|
|
|
|
|
CANCEREPIDEMIOLOGY
|
|
|
|
|
CANCER ASSOCIATED, TPA
|
|
|
|
|
CANCER ANTIGEN (CA 27-29)
|
|
|
|
|
CANCER ANTIGEN (CA-50)
|
|
|
|
|
CancerSirnaMetastasisSubset
|
|
|
|
|
CancerAntigenCa125(OvarianCancer)CalibratorGrade
|
|
|
|
|
CancerAntigenCa19-9(GastrointestinalCancer)AntigenGrade
|
|
|
|
|
CancerAntigenCa125(OvarianCancer)AntigenGrade
|
|
|
|
|
CancerAntigenCa15-3(BreastCancer)
|
|
|
|
|
CancerAntigenCa72-4AntigenGrade
|
|
|
|
|
CancerAntigenCa19-9(GastrointestinalCancer)
|
|
|
|
|
CancerAntigenCa15-3(BreastCancer)AntigenGrade
|
|
|
|
|
CancerSirnaDNARepairSubset
|
|
|
|
|
Cancer Associated Antigen, Breast Tumor, Human Fluids
|
|
|
|
|
CancerAntigenCa19-9(GastrointestinalCancer)CalibratorGrade
|
|
|
|
Cancentrine
|
29477-90-5
|
C36H34N2O7
|
|
|
CancerAntigenCa125(OvarianCancer)GroupA
|
|
|
|
|
CancerAntigenCa15-3(BreastCancer)CalibratorGrade
|
|
|
|
|
CancerAntigenCa125(OvarianCancer)CalibratorGrade(LowCrossReactivity)
|
|
|
|
|
CancerAntigenCa50CalibratorGrade
|
|
|
|
|
CancerSirnaApoptosisSubset
|
|
|
|
|
CancerSirnaCellCycleSubset
|
|
|
|
|
Cancer Vaccines
|
|
|
|
|
cancer-associated retinopathy antigen
|
135844-11-0
|
|
|
|
cancer suppressive factor
|
|
|
|
|
cancer-recognition, immunedefense suppression, serine protease protection peptide
|
|
|
|
|
CancerAntigenCa15-3(BreastCancer)CalibratorGrade(LowCrossReactivity)
|
|
|
|
|
CancerAntigenCa125(OvarianCancer)GroupB
|
|
|
|
|
CancerSirnaGrowthFactorSubset
|
|
|
|
|
CancerAntigenCa125(OvarianCancer)
|
|
|
|
|
CancerSirnaAngiogenesisSubset
|
|
|
|
|
CancerSirnaTumorSuppressorSubset
|
|
|
|
|
CancerBulkMaterials
|
|
|
|
|
CBDcenA*TAG PRIMER
|
|
|
|
|
Cancer Associated Antigen, TAG-72, Human Fluids
|
|
|
|
|
CA 0.45 500MM 2-222FPM/FLAT CLOSED
|
|
|
|
|
CA 0.45 250MM 2-222FPM/FLAT CLOSED
|
|
|
|
|
CA 0.45 500MM 2-222/FLAT CLOSED
|
|
|
|
|
CANDALUM (RHODIA)
|
|
|